Eastwood Bio-Medical Canada Inc. (EWOOF)
Eastwood Bio-Medical Canada Inc. operates in the Food Distribution industry of the Consumer Defensive sector, headquartered in Richmond, BC, CA. The stock last traded at $0.69, giving a market capitalisation of $47.8M. On trailing twelve-month figures it carries a trailing P/E of -482.76, a net margin of -28.2%. Its beta of 0.28 implies it has historically moved less than the broad market.
Eastwood Bio-Medical Canada Inc. specializes in the marketing and distribution of natural health products under its proprietary Eleotin brand. The company's reach extends across Canada, the United States, and Asia. Its primary focus is on providing natural remedies for metabolic health concerns, such as blood glucose imbalances, high blood pressure, and obesity. The diverse Eleotin product range includes several licensed formulations: Eleotin A 700: Addresses spleen deficiency, poor appetite, and fatigue. Eleotin AL88: Functions as a laxative. Eleotin Cal20 & V3D: Both contribute to the development and maintenance of healthy bones and teeth, with V3D additionally promoting overall good health. Eleotin G2000: Supports cardiovascular well-being. Eleotin H55: Offers sedative effects and helps alleviate tension. Eleotin Zn330: Aids in tissue formation and metabolism. Additionally, the company offers Eleotin Bentley to assist in maintaining healthy glucose levels and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was founded in 2010 and is based in Richmond, Canada.
Eastwood Bio-Medical Canada Inc. is most often compared with the following Consumer Defensive names: